Price T Rowe Associates Inc Viatris Inc Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Viatris Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 78,772,616 shares of VTRS stock, worth $797 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
78,772,616
Previous 74,461,308
5.79%
Holding current value
$797 Million
Previous $649 Million
8.46%
% of portfolio
0.08%
Previous 0.08%
Shares
19 transactions
Others Institutions Holding VTRS
# of Institutions
1,123Shares Held
986MCall Options Held
7.82MPut Options Held
2.94M-
Vanguard Group Inc Valley Forge, PA145MShares$1.47 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$938 Million0.02% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$672 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$560 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX31.3MShares$316 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...